Company Performance: BIOKA.AT's revenue, profit margins, and overall financial health directly impact investor confidence and stock valuation.

Industry Trends: Developments in the biotechnology and pharmaceutical industries, including new drug approvals and market growth, can influence BIOKA.AT's stock price.

Regulatory Environment: Changes in government regulations regarding drug development, pricing, and healthcare policies affect BIOKA.AT's operations and profitability.

Market Sentiment: General investor optimism or pessimism towards the stock market and specific sectors can drive buying or selling pressure on BIOKA.AT shares.

Competition: The competitive landscape, including the presence of rival companies and alternative treatments, influences BIOKA.AT's market share and stock performance.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and GDP growth can impact BIOKA.AT's business and stock valuation.

News and Events: Company-specific news, such as clinical trial results, partnerships, or acquisitions, can trigger significant stock price movements.

Investor Perception: Investor's overall perception of company, including if they like the technology or have concerns, can increase or decrease demand for the stock.